This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Prolong Pharmaceuticals, LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovations of Peter Joseph Buontempo
Introduction
Peter Joseph Buontempo is an accomplished inventor based in Westfield, NJ (US). He is known for his significant contributions to the field of hemoglobin compositions, particularly through his innovative work at Prolong Pharmaceuticals, LLC. His research focuses on enhancing the capabilities of hemoglobin for medical applications.
Latest Patents
Peter Joseph Buontempo holds a patent for hemoglobin compositions. This invention provides compositions containing hemoglobin, particularly PEGylated hemoglobin. The PEGylated hemoglobin molecule is capable of transferring oxygen or carbon monoxide bound thereto to a tissue or red blood cells with which it is in proximity. Exemplary PEGylated hemoglobin formulations of the invention are virally inactivated. Various compositions of the invention include hemoglobin, which may be conjugated with one or more water-soluble polymer. PEGylated hemoglobin includes those species in which the iron atom of the hemoglobin molecule is not bound to oxygen or any other species, and hemoglobin molecules in which a species other than oxygen, e.g., carbon monoxide, is bound to the iron atom. The compositions of the invention are formulated as hypo-, iso- or hypertonic solutions of the PEGylated hemoglobin. The compositions are of use to treat and/or ameliorate disease, injury, and insult by providing for the oxygenation of tissues and/or organs. He has been granted 1 patent for this innovative work.
Career Highlights
Throughout his career, Peter has made significant strides in the field of biotechnology. His work at Prolong Pharmaceuticals, LLC has positioned him as a key player in the development of advanced hemoglobin therapies. His research has the potential to revolutionize treatments for various medical conditions.
Collaborations
Peter Joseph Buontempo has collaborated with notable professionals in his field, including Abraham Abuchowski and Glenn Kazo. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Peter Joseph Buontempo is a notable inventor whose work in hemoglobin compositions has the potential to significantly improve medical treatments. His innovative approach and collaborations highlight his commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile